In this study, we identified the main hydroxylated polychlorinated biphenyls (OH-PCBs) and other chlorinated phenolic compounds and we determined their relative concentrations in whole blood from 13 male and 17 female Inuit from northern Quebec, Canada, and from a pooled whole blood sample from southern Quebec. We also determined concentrations of polychlorinated biphenyls (PCBs). Total OH-PCB concentrations were variable among the Inuit samples, ranging over 2 orders of magnitude (0.117-11.6 ng/g whole blood wet weight). These concentradions were equal to and up to 70 times those found for the southern Quebec pooled whole blood sample. Geometric mean concentrations of tota OH-PCBs were 1.73 and 1.01 nglg whole blood for Inuit men and women, respectively, and 0.161 nglg whole blood for the southern population pool. There are limited data available for comparison, but the levels of OH-PCBs in Imuit are higher thn those previously reported in the literature for other populations. There was a significant correlation (p < 0.005) between OH-PCBs and PCBs (r = 0.84) and both correlated significandy (p < 0.005) with age (r= 0.68 and 0.78, respectively). The ratio of OH-PCBs to PCBs was lower in Inuit (0.11) than in the southern Quebec pool (0.33). There is no apparent explanation for the difference. There was considerable variability in the congener pattem of the identified OH-PCBs. The main metabolite, 4-OH-CB109 (4-0H-2,3,3',4',5-pentachlorobiphenyl), constituted 12-62% of the total OH-PCBs in the samples. Pentachlorophenol (PCP) was the dominant phenolic compound in blood, constituting 46% (geometric mean) of the total quantitated chlorinated phenolic compounds. PCP concentrations in Imuit blood ranged from 0.558 to 7.77 ng/g on a wet weight basis. All but two Inuit samples had lower concentrations than the southern Quebec pool (6.29 ng/g). The possible role of OH-PCBs in mediating PCB-induced adverse effects needs to be investigated fiuther.
httpnx/ehpnetl.niehs.nih.fov/docs/2000/108p611-616sandau/abstra.thtml Polychlorinated biphenyls (PCBs) have been extensively studied since their discovery as environmental pollutants over 30 years ago (1) . Their persistence in biota is well known but the mechanism of their adverse effects on biologic systems is still not completely understood. Some of their toxicity may be linked to the biotransformation products of PCBs (2) . PCBs are biotransformed by a diverse enzyme system, the cytochrome P450 monooxygenases. Most of the known metabolic pathways involve the initial formation of hydroxylated metabolites. Even one of the more recalcitrant PCBs, CB153, is metabolized in vitro and in vivo to a number of phenolic metabolites (3) (4) (5) . Phenolic metabolites can be excreted unchanged, as they were first discovered in the excreta of Baltic seals and Guillemots (6) , or further conjugated with glucuronic acid or sulfate (7) . The introduction of a hydroxyl group increases the polarity of the PCB and facilitates excretion. If the hydroxyl group is para to the phenyl-phenyl bond and has adjacent chlorine atoms, the structure resembles the prohormone, thyroxin (T4) (8) . This structural similarity allows hydroxylated polychlorinated biphenyls (OH-PCBs) to bind with high affinity to one of the thyroid hormone transport proteins, transthyretin (TTR) (9) (10) (11) (12) . For example, 4-OH-3,3',4,5'-tetrachlorobiphenyl, a metabolite of CB77, has a binding affinity to TTR 4 times stronger than that of T4 (9) , and can disrupt thyroid hormone and retinol (vitamin A) transport (13) . This is the presumed mechanism by which OH-PCBs are selectively retained in plasma and is a possible mechanism of PCB toxicity (14) . This type of interaction is not limited to OH-PCBs. Pentachlorophenol (PCP) binds with 2 times the affinity of T4 to TTR (15) , indicating that other chlorinated phenolic compounds may also be interfering in thyroid hormone transport.
Some Inuit consume traditional foodstuffs consisting of fatty tissues from sea mammal species such as ringed seal and beluga (16) (17) (18) . Ringed seal blubber, beluga skin, and beluga blubber in northern Canada contain average total PCB concentrations of 1,283, 145, and 5,000 ng/g wet weight, respectively (19, 20) , which is much higher than that in the diet of the general population (21) . Thus, the Inuit population may be exposed to large doses of PCBs. In one study, mean PCB blood levels in Inuit were 30 times those of a southern population (22) . An increased PCB body burden could result in the increased formation of metabolites due to induction of the P450 system. Increased levels of metabolites may be significant enough to disrupt thyroid hormone transport. Alterations of thyroid hormone status have been proposed as a mechanism of action by which PCBs would induce adverse neurodevelopmental effects (23 Because analysis was carried out on methylated OH-PCBs, we used a standard mixture of MeO-PCBs. The MeO-PCB mixture included 4'-MeO-2,3',4,5,5'-pentachlorobiphenyl (4'-MeO-CB120);supplied by A. Bergman (Wallenberg Laboratories, Stockholm, Sweden), and synthesized as described elsewhere (29) . We used the MeO-PGBs for quantitation by the external standard method.
We used a serial dilution of the MeO-PCB mixture for quantitation. We generated response factors relative to the performance standard (RRFs) for each of the compounds in the standard mixture. The RRFs were then used to quantitate all identified and unidentified OH-PCBs in each sample by the external standard method, with volume correction using the performance standard. Identified compounds were quantitated using their RRF. Structures were considered confirmed if they had identical spectra and matching retention times on three GC columns with varying polarities (DB5, DB1701, and DB210; J&W Scientific, Inc.). We characterized unidentified compounds by full scan mass spectrometry to determine the chlorination pattern. The average RRFs for that chlorination pattern were used for quantitation for the unidentified compounds. The RRFs for compounds with a given chlorination and methoxy group substitution were comparable. For example, the RRFs for the para-methoxylated heptachlorobiphenyls were all within 10% of the average RRF. We determined recoveries using the 13C12 OH-PCB standards and 4'-Me-4-MeO-2,3,3',5,6-pentachlorobiphenyl as the performance standard. PCP was quantitated by isotope dilution using the 13C6 internal recovery standard correcting for the 3.4% contribution of native PCP (m/z = 280 amu) to the main ion of the 13C6 standard (n/z = 286 amu) duster.
PCBs were quantitated on a congenerspecific basis by the external standard method using an Aroclor 1242:1254:1260
(1:1:1) secondary quantitation standard solution calibrated against primary standard PCB congener solutions provided by the National Research Council of Canada (Marine Analytical Chemistry Standards Program, Halifax, Nova Scotia, Canada). We determined concentrations of congeners for which standard solutions were not available in the Aroclor mixture by GC using flame ionization detection (30) . We 
Results
Whole blood recoveries of OH-PCBs were variable, ranging from 50 to 105%. The mean recoveries for 13C12-4'-OH-CB120, -4'-OH-CB159, -4'-OH-CB172 and -4-OH-CB187 were 82, 69, 72, and 76%, respectively. This was the first study to use 13C12-labeled OH-PCBs for accurate OH-PCB quantitation. PCB recoveries had a slightly lower mean recovery of 60%. All PCB and OH-PCB concentrations were consequently recovery corrected.
An example chlorinated phenolic ECNI-MS full scan chromatogram is given in Figure 2 . The major peaks are identified when known. The OH-PCB fraction in Inuit whole blood contained > 30 congeners, of which 11 were positively identified with authentic standards. Positive identification is based on identical mass spectra using full scan ECNI mass spectrometry and matching retention times using three GC columns with varying polarities (results not shown). All identified congeners are listed in Table 1 . The congeners constituted between 59 and 81% of the total OH-PCBs in the samples (mean = 70%).
We did not determine the lipid content of the whole blood samples. Therefore, all concentrations hereafter are expressed on a whole blood wet weight basis. The concentrations. The arithmetic mean of the total OH-PCBs in Inuit whole blood was 1.89 times greater than the geometric mean. Therefore, the difference in geometric mean values between pop'ulations is probably an overestimate of the geometric mean and the differences in concentrations are even greater than indicated in Table 1 . PCP was the main chlorinated phenolic compound in the Inuit whole blood. It contributed between 14 and 89% of the total chlorinated phenolic compounds quantitated. The concentration of PCP ranged from 0.558 to 7.77 ng/g with a geometric mean of 2.02 ng/g wet weight. The pooled whole blood sample from the southern population had higher PCP levels than all but two Inuit samples analyzed, with a concentration of 6.29 ng/g. PCP composed 97% of the total quantitated chlorinated phenolic compounds in the southern population.
The major OH-PCB congeners varied considerably among individuals. The mean ratios of the five main congeners to total OH-PCBs are shown in Figure 3 , with bars representing the range. The main congener identified in Inuit whole blood (21 of 30 samples) was 4-OH-CB109, with a geometric mean concentration of 0.266 ng/g and a range of 0.015-2.55 ng/g. This congener is probably a mixture of two congeners, 4-OH-CB109 (4-OH-2,3,3',4',5-pentachlorobiphenyl) and 4'-OH-CB107, because they coelute and because separation was not achieved with the DB-5 column used in this study. This peak was quantitated using only 4'-OH-CB107 as the quantitation standard because 4-OH-CB109 was not commercially available. The peak is assumed to be predominantly 4-OH-CB109 because it is the dominating compound of the mixture in human plasma at a 5:1 excess (14,31). However, considering pattern variability this would need to be confirmed for each sample in the future. (24) . When the Swedish data are approximated to plasma equivalents, these levels are the same order of magnitude and have a similar range as those for the Inuit and the southern Quebec pooled whole blood samples. The plasma equivalent was estimated by assuming that whole blood is approximately half plasma by weight and that the average plasma lipid levels in the population are approximately 1%.
Although the concentration of PCP is lower in Inuit than that measured in the southern Quebec pooled whole blood sample, it may still play a role in the disruption of thyroid hormone transport. PCP binds to TTR with twice the affinity of the native 
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Articles * Hydroxylated metabolites in Inuit whole blood hormone (15) and is responsible for 14-89% of the total phenolic comnpounds quantitated. Geyer et al. (34) calculated the half-life of PCP as approximately 19 days and concluded that the German cohort's calculated intake of PCP exceeded the elimination rate and approximated a bioconcentration factor of 1.4 for blood. This is likely due to binding with TTR and explains the high levels of PCP found in blood. Considering the significance of PCP in the chlorinated phenolic fraction, further investigation of PCP and its possible effects on thyroid hormone transport is required, especially for southern populations, where levels of PCP far exceed OH-PCBs and other chlorinated phenolic compounds.
Another major compound in the Inuit whole blood chromatogram is an unidentified chlorinated phenolic compound that elutes just before the OH-PCBs. The major ion cluster for this compound, using the given mass spectrometry conditions, has an isotope pattern indicative of a hexachlorinated compound. Therefore, the levels were approximated using the C16 response factor from the OH-PCB standard mixture. Based on approximate concentrations, the compound accounts for 1-17% of total chlorinated phenolic compounds in the Inuit. Levels occasionally exceeded those of the main OH-PCBs. Further work on the identification and accurate quantitation of this unknown compound is currently underway.
The chromatogram of the phenolic compound fraction consists of > 30 peaks that were identified as hydroxylated metabolites of PCBs based on their mass spectra. These represent 20% of the total chlorinated phenolic compounds, on average, in Inuit whole blood (range 2-56%). OH-PCBs constitute a significantly more important proportion of the total chlorinated phenolic compounds in Inuit as compared to the general population pooled sample, in which OH-PCBs represent only 1.2% of the estimated total.
The mean concentration of the five main OH-PCBs (1.47 ng/g) in Inuit samples is slightly higher than that of a Swedish general population cohort (1.0 ng/g) (31) . The Swedish data have been adjusted to whole blood wet weight equivalents. It was expected that levels of OH-PCBs in Inuit would be higher than those found because the mean PCB levels in plasma were 3 times that of this particular Swedish population, and an average of 30 times (range 2.5-133) that of the southern Quebec pooled sample. The range of the sum of these five congeners in the Swedish study (0.35-1.65 ng/g) is small as compared to concentrations in the Inuit population, which range from 0.059 to 7.07 ng/g plasma wet weight levels of OH-PCBs.
The higher levels of OH-PCBs are likely due to the higher levels of parent PCBs. OH-PCBs were significantly correlated with PCBs (r = 0.84, p < 0.005), as expected.
The strong linear relationship observed between concentrations of PCBs and their metabolites suggests that no changes in enzyme activity affecting the rate of formation or saturation of OH-PCBs binding to plasma proteins are taking place for this range of PCB exposure. The concentration of total quantitated chlorinated phenolic compounds was < 2% of the theoretical molar circulating concentration of TTR in an average human (35) . Thus, it is not likely that the concentration of total chlorinated phenolic compounds reached the carrying capacity of the blood, assuming that Inuit have similar TTR concentrations as the published values from other populations (35) .
Women had lower mean concentrations of all phenolic compounds quantitated than men. The generally lower levels in women may result from the loss of OH-PCBs and PCBs through lactation because both have been identified in milk (36) (37) (38) . Both OH-PCBs and PCBs were significantly correlated with age (r = 0.68 and 0.78, respectively; p < 0.05). The increase of both PCB and OH-PCB concentrations with age may be due to the increased exposure with age (elders' preference for traditional foods), a slow excretion rate of PCBs that prevents steady state from being achieved, or both. A positive association between age and PCB levels in breast milk was reported previously in southern Quebec women (39) and in Inuit adults from Nunavik (22) .
The concentration of omega-3 fatty acids in plasma phospholipids is a good indicator of fish intake (40Q. In (41) . Thus, an increase in the intake of traditional foods with age is indicated, and is probably partly responsible for the increase in PCBs with age. However, indications of increasing concentration of PCBs with age in other populations suggest that slow excretion of PCBs is also important.
The main OH-PCBs identified in previous studies were also the dominating congeners in the Inuit population ( Figure 2 The main metabolite in most of the remaining samples was 4-OH-CB187, which was previously identified as the major metabolite in a Swedish population (14) . This compound was also identified as the main metabolite for the southern Quebec pooled sample and in other species including polar bears (33) and albatrosses (32) . This metabolite is most likely formed from the metabolism of CB183 and/or CB 187, which represent 2 and 5%, respectively, of the Aroclor 1254 mixture (43) .
The OH-PCB pattern present in the chlorinated phenolic compound fraction in plasma is complex and it is difficult to generalize patterns in humans from such a small data set. The ratio of 4-OH-CB109 to total OH-PCBs ranged from 0.12 to 0.62 (mean = 0.34) (Figure 3) . The remaining congeners in the Inuit all composed similar proportions of total OH-PCBs as compared to the southern population. The ratio of the five main congeners to CB153 in the southern pooled samples was within the range of those determined for the Inuit samples, except for 4-OH-CB 187, where the southern pooled sample was higher than all of the Inuit samples.
A number of factors, which include exposure to different proportions of precursor PCBs, alteration of metabolism rates by induction of hepatic enzymes, inhibition of the metabolizing enzymes and the proteinbinding specificity of the plasma, may all influence the retention of hydroxylated metabolites. Genetic diversity among individuals and populations may also influence the metabolism rates and binding specificity.
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To evaluate the toxicologic significance of the phenolic fraction, the main compounds must be identified, accurately quantitated, and toxicologic studies must be undertaken to evaluate the effects of these compounds on thyroid hormone and retinol homeostasis and binding at receptor sites. PCP remains the dominating phenolic compound in Inuit whole blood, even more so for the southern Quebec pooled sample. Concentrations of PCP in most of the samples far exceeded the main OH-PCBs. Other compounds, such as the unknown chlorinated compound, will be researched further to elucidate structure and possible roles in disruption of thyroid hormone transport.
In condusion, total OH-PCB concentrations were 11 and 33% of total PCB concentrations in Inuit and a southern Quebec pooled sample of whole blood, respectively. Both total PCB and total OH-PCB geometric mean concentrations were higher for Inuit than for the southern Quebec pooled sample and the current literature values (31 
